These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22350116)

  • 41. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
    Cohen SY; Bulik A; Dubois L; Quentel G
    Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.
    Shaikh S; Ruby AJ; Williams GA
    Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
    Essex RW; Qureshi SH; Cain MS; Harper CA; Guymer RH
    Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.
    Besozzi G; Sborgia L; Furino C; Cardascia N; Dammacco R; Sborgia G; Modoni AP; Boscia F
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):497-502. PubMed ID: 19916015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
    Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
    Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.
    Pece A; Isola V
    Eur J Ophthalmol; 2008; 18(5):841-4. PubMed ID: 18850572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin.
    Blair MP; Apte RS; Miskala PH; Bressler SB; Goldberg MF; Schachat AP; Bressler NM
    Retina; 2004 Aug; 24(4):501-6. PubMed ID: 15300069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.
    Menchini U; Virgili G; Introini U; Bandello F; Ambesi-Impiombato M; Pece A; Parodi MB; Giacomelli G; Capobianco B; Varano M; Brancato R
    Retina; 2004 Oct; 24(5):763-71. PubMed ID: 15492632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults.
    Rogers AH; Duker JS; Nichols N; Baker BJ
    Ophthalmology; 2003 Jul; 110(7):1315-20. PubMed ID: 12867384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia.
    Hayashi K; Ohno-Matsui K; Shimada N; Moriyama M; Hayashi W; Wang J; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2011 Jan; 151(1):137-147.e1. PubMed ID: 20970774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.
    Glacet-Bernard A; Benyelles N; Dumas S; Haddad WM; Voigt M; Razavi S; Roquet W; Coscas G; Soubrane G
    Am J Ophthalmol; 2007 Jan; 143(1):68-76. PubMed ID: 17188042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.
    Potter MJ; Szabo SM; Ho T
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):639-41. PubMed ID: 16175378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.